Neogenomics Inc (NASDAQ:NEO)

8.03
Delayed Data
As of Feb 23
 -0.22 / -2.67%
Today’s Change
7.08
Today|||52-Week Range
11.63
-9.37%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close8.25
Today’s open8.24
Day’s range7.78 - 8.34
Volume867,033
Average volume (3 months)419,580
Market cap$663.4M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-875.00%
Earnings growth (this year)-20.74%
Earnings growth (next 5 years)+29.70%
Revenue growth (last year)+144.57%
P/E ratioNM
Price/Sales2.72
Price/Book3.96

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc+0.03+0.33%
ENZEnzo Biochem Inc-0.04-0.59%
KANGiKang Healthcare Gro...+0.10+0.62%
RDNTRadNet Inc+0.10+0.99%
Data as of 4:02pm ET, 02/23/2018

Financials

Next reporting dateApril 25, 2018
EPS forecast (this quarter)$0.04
Annual revenue (last year)$244.1M
Annual profit (last year)-$5.7M
Net profit margin-2.34%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Scientific Officer &
VP-Operations
Steven G. Brodie
Corporate headquarters
Fort Myers, Florida

Forecasts